Google Übersetzer
Eton Pharmaceuticals Inc
About
Eton Pharmaceuticals Inc (NASDAQ:ETON) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 16 2026
Eton Pharmaceuticals Announces CFO Succession Plan
Mar 19 2026
Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results
Mar 3 2026
Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, March 19, 2026
Mar 2 2026
Eton Pharmaceuticals Expands Rare Disease Portfolio Through Acquisition of U.S. Commercialization Rights to HEMANGEOL® (propranolol hydrochloride) Oral Solution
Feb 25 2026
Eton Pharmaceuticals Announces U.S. FDA Approval for DESMODA™ (desmopressin acetate) Oral Solution